Martin Shaw, Business Development at AroCell, held a presentation on the Thymidine Kinase 1 immunoassay, highlighting its significance as a valuable translational biomarker from drug discovery through to clinical trials. You can see the presentation below.
AroCell’s Innovations and Future Prospects Presented at Redeye’s Event
AroCell participated at Redeye's Technology & Life Science day on December 3rd. CEO Anders Hultman presented the latest developments and future prospects of the company. The presentation is now available for listening below. AroCell: CEO Anders Hultman presenterar...
